PHARMACIE QUIN-HALFKAN
ActiveSummary
PHARMACIE QUIN-HALFKAN has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €77k and a net result of €41k. Equity is shrinking by ~5.9% per year across the filed fiscal years. Its solvency ranks better than 22% of 10359 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2025
56
/ 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability77▼-4
Solvency37▼-9
Growth32▼-46
Track record100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4k at 30 days acceptable
Liquidity tight (current ratio 1.21 against 1.42 in 2024; short-term debt: 62.5% and cash: 4.8% of total assets), and 88% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
12%
Return on assets
6.3%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 22% of 10359 sector peers (2025).
NBB · sector comparisonPosition among 10359 sector peers
Solvency
better than 22%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
2 d early
2024
1 d early
2023
21 d late
2022
28 d late
2021
18 d early
2020
30 d late
2019
31 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€41k▼ 33.0%
2024 · €61k
2018: €44k
2019: €48k
2020: €46k
2021: €65k
2022: €81k
2023: €75k
2024: €61k
2018 → 2025
Working capital
€83k▼ 35.9%
2024 · €129k
2018: €-83k
2019: €-71k
2020: €5k
2021: €12k
2022: €86k
2023: €50k
2024: €129k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€142k-€125k▼ 11.8%€75k▼ 39.6%€137k▲ 80.8%€77k▼ 43.3%
Operating result€99k-€118k▲ 18.9%€113k▼ 4.2%€99k▼ 12.5%€62k▼ 37.0%
Net result€65k-€81k▲ 24.0%€75k▼ 6.4%€61k▼ 19.2%€41k▼ 33.0%
Result per fiscal year
Operating resultNet result
The operating result has fallen three years in a row; 2025 is 37% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €646k
Fixed assets
€160k ▼ 22.6%
Current assets
€486k ▲ 11.2%
Equity and liabilities €646k
Equity
€77k ▼ 43.3%
Debt
€568k ▲ 12.1%
Debt's share of the balance-sheet total rises from 78.8% to 88.0%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€121k▼
2024 · €156k
Cash flow
€99k▼
2024 · €118k
Current ratio
1.21▼
2024 · 1.42
Quick ratio
0.70▼
2024 · 0.77
Debt to equity
7.34▲
2024 · 3.71
ROE
52.8%▲
2024 · 44.7%
ROA
6.3%▼
2024 · 9.5%
Interest coverage
12.75▲
2024 · 9.58
Debt ≤ 1 year
€403k▲
2024 · €308k
Debt > 1 year
€165k▼
2024 · €199k
Income taxes
€15k▼
2024 · €22k
Staff costs
€209k▲
2024 · €145k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 50 lines
Balance sheet
Code20242025
Assets
Total assets20/58€643k€646k▲
Fixed assets21/28€206k€160k▼
Intangible fixed assets21€45k€15k▼
Tangible fixed assets22/27€161k€144k▼
Land and buildings22€83k€76k▼
Plant, machinery and equipment23€11k€13k▲
Furniture and vehicles24€67k€56k▼
Current assets29/58€437k€486k▲
Stocks and contracts in progress3€200k€206k▲
Stocks30/36€200k€206k▲
Amounts receivable within one year40/41€114k€249k▲
Trade receivables40€114k€118k▲
Other amounts receivable41-€131k
Cash at bank and in hand54/58€103k€31k▼
Deferred charges and accrued income490/1€20k€117▼
Equity and liabilities
Total equity and liabilities10/49€643k€646k▲
Equity10/15€137k€77k▼
Contributions10/11€1€1=
Profit (loss) carried forward14€137k€77k▼
Amounts payable17/49€507k€568k▲
Amounts payable after more than one year17€199k€165k▼
Financial debts170/4€49k€11k▼
Other amounts payable178/9€150k€154k▲
Amounts payable within one year42/48€308k€403k▲
Current portion of amounts payable after more than one year42€42k€38k▼
Trade debts44€202k€215k▲
Suppliers440/4€202k€215k▲
Taxes, remuneration and social security45€36k€51k▲
Taxes450/3€13k€16k▲
Remuneration and social security454/9€23k€35k▲
Other amounts payable47/48€27k€100k▲
Income statement
Code20242025
Remuneration, social security and pensions62€145k€209k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€57k€58k▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€16k
Other operating charges640/8€1€2▲
Gross operating margin9900€301k€345k▲
Operating profit (loss)9901€99k€62k▼
Financial income75/76B€303€3k▲
Recurring financial income75€303€3k▲
Financial charges65/66B€16k€9k▼
Recurring financial charges65€16k€9k▼
Profit (loss) for the period before taxes9903€83k€56k▼
Income taxes67/77€22k€15k▼
Profit (loss) for the period9904€61k€41k▼
Profit (loss) for the period to be appropriated9905€61k€41k▼
Appropriation of the result
Profit (loss) to be appropriated9906€137k€177k▲
Profit (loss) brought forward from the previous period14P€75k€137k▲
Profit to be distributed694/7-€100k
Return on contributions (dividend)694-€100k
Social balance
Average headcount (FTE)90872.63.3▲
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Weakest financial yearnet €41k ▼33%
Net result drops to €41k, the lowest in the series.
30-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Equity above €100kEq €137k ▲80.8%
7 profitable years in a row build equity to €137k.
21-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 21 days late
2023
28-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 28 days late
2022
31-12
Financial
Highest result since 2018net €81k ▲24%
Operating result €118k, net result €81k, both a record.
13-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
30-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 30 days late
2020
30-06
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial
Equity above €150kEq €153k ▲45.3%
2 profitable years in a row build equity to €153k.
19-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
26-06
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
29-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Quiévrain · 1 establishment unit since 2016
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue de l'Eglise 237382 QuiévrainGround area
339 m²
Building footprint
124 m²
Volume, LiDAR
831 m³
Parcel 53005B0254/00D000, Wallonia · tallest building 8.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
PHARMACIE QUIN-HALFKAN
since 20162.255.345.713
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 53005B0254/00D000 | Wallonia | 339 m² | 1 · 124 m² | 8.8 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteQuiévrain2.255.345.713
Similar companies · same sector, comparable size
Pharmacie Valentin
BE 0882.212.426
Morlanwelz · Eq €77,397
PHARMACIE DE CAMPINE
BE 0782.313.215
Liège · Eq €77,410
PHARMACIE GERARD
BE 0759.853.260
Visé · Eq €77,222
APOTHEEK HUSTINGS
BE 0434.586.031
Wellen · Eq €77,740
MZOUGUI
BE 0899.686.975
Fosses-la-Ville · Eq €77,902
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,221 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded21-06-2016
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 10 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryPhone:065/46.09.75